← Back to Search

Neuromuscular Blocker

Botox for COPD

Q: Has Treatment Arm been given the go-ahead from the FDA?

There is limited clinical evidence supporting the safety of Treatment Arm, so it receives a score of 2.

Q: Are there any available slots left for participation in this clinical experiment?

According to clinicaltrials.gov, the initial posting date for this trial was on September 1st 2023 and it has not been updated since August 17th 2023. Consequently, there are no openings in this study; however, 299 other studies have open positions available at present.

Q: Does this experiment provide opportunity for participants aged 35 or older?

This clinical trial specifically requests patients in the 18-85 years old demographic, though there are many other studies with either younger or older cohorts. Specifically, 14 trials involve minors and 293 look at adults above 65.

Q: Is it possible for me to participate in this research program?

Those afflicted with <a href="https://www.withpower.com/clinical-trials/copd">COPD</a>, aged between 18 and 85 years old, have the option of taking part in this trial. However, only those able to receive injections along their spine/back in the T-1 > T-5 region and who possess a confirmed moderate diagnosis from a doctor can be considered for enrolment.

Phase 2

Recruiting

Led By Victoria Do

Research Sponsored by RMW Testing

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 90 days

Awards & highlights

Study Summary

This trial tests if Botox injections can improve COPD symptoms in people with moderate COPD.

Who is the study for?

Adults with moderate COPD who can consent and receive back injections, have a specific lung function score (FEV1/FVC < 0.7), experience certain levels of breathlessness, and are not current smokers. Women must test negative for pregnancy and use contraception; men should also use effective contraception.Check my eligibility

What is being tested?

The trial is testing the safety and effectiveness of BOTOX injections to alleviate symptoms in adults with moderate COPD compared to a placebo. Participants will receive subcutaneous injections along their spine.See study design

What are the potential side effects?

Potential side effects may include pain at the injection site, muscle weakness near where the medicine was injected, trouble swallowing or breathing if the medication spreads beyond the injection site, allergic reactions, or flu-like symptoms.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 90 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~90 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

CAT (Average)

Secondary outcome measures

Adverse Reactions

CAT (Change in Units)

COPD Exacerbations

Other outcome measures

6MWT

CAT Score

FEV1

+2 more

Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: Treatment ArmActive Control1 Intervention

OnabotulinumtoxinA

Group II: Placebo ArmPlacebo Group1 Intervention

Normal saline

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

RMW TestingLead Sponsor

Victoria DoPrincipal InvestigatorInvestigator

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has Treatment Arm been given the go-ahead from the FDA?

"There is limited clinical evidence supporting the safety of Treatment Arm, so it receives a score of 2."

Answered by AI

Are there any available slots left for participation in this clinical experiment?

"According to clinicaltrials.gov, the initial posting date for this trial was on September 1st 2023 and it has not been updated since August 17th 2023. Consequently, there are no openings in this study; however, 299 other studies have open positions available at present."

Answered by AI

Does this experiment provide opportunity for participants aged 35 or older?

"This clinical trial specifically requests patients in the 18-85 years old demographic, though there are many other studies with either younger or older cohorts. Specifically, 14 trials involve minors and 293 look at adults above 65."

Answered by AI

Is it possible for me to participate in this research program?

"Those afflicted with COPD, aged between 18 and 85 years old, have the option of taking part in this trial. However, only those able to receive injections along their spine/back in the T-1 > T-5 region and who possess a confirmed moderate diagnosis from a doctor can be considered for enrolment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Study to Evaluate Safety and Efficacy of BOTOX in Adults With Moderate COPD

2023. "A Study to Evaluate Safety and Efficacy of BOTOX in Adults With Moderate COPD". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06003049.